Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2007
HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective studyMaurice P H M Jansen, Anieta M Sieuwerts, Maxime P Look, et al.
Molecular Oncology|February 7, 2017
Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditionsLisanne F van Dessel, Nick Beije, Jean C A Helmijr, et al.
Breast Cancer Research and Treatment|February 27, 2008
TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancerDanielle Meijer, Maurice P H M Jansen, Maxime P Look, et al.
Breast Cancer Research and Treatment|July 13, 2011
Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genesMuhammad Riaz, Els M J J Berns, Anieta M Sieuwerts, et al.
Science Translational Medicine|January 25, 2013
KLF6-SV1 drives breast cancer metastasis and is associated with poor survivalRaheleh Hatami, Anieta M Sieuwerts, Sudeh Izadmehr, et al.
Scientific Reports|May 20, 2017
Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancerTommaso De Marchi, Mieke A Timmermans, Anieta M Sieuwerts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy responseJozien Helleman, Maurice P H M Jansen, Kirsten Ruigrok-Ritstier, et al.
Plos One|January 21, 2017
Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast CancerSimone U Dalm, Willemijne A M E Schrijver, Anieta M Sieuwerts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patientsAnieta M Sieuwerts, Maxime P Look, Marion E Meijer-van Gelder, et al.
Lancet (London, England)|February 22, 2005
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerYixin Wang, Jan G M Klijn, Yi Zhang, et al.
Pageof 6